These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26362901)

  • 1. Multiple sclerosis lesion formation and early evolution revisited: A weekly high-resolution magnetic resonance imaging study.
    Guttmann CR; Rousset M; Roch JA; Hannoun S; Durand-Dubief F; Belaroussi B; Cavallari M; Rabilloud M; Sappey-Marinier D; Vukusic S; Cotton F
    Mult Scler; 2016 May; 22(6):761-9. PubMed ID: 26362901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
    Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
    PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study.
    Sinnecker T; Mittelstaedt P; Dörr J; Pfueller CF; Harms L; Niendorf T; Paul F; Wuerfel J
    Arch Neurol; 2012 Jun; 69(6):739-45. PubMed ID: 22351849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.
    Cotton F; Weiner HL; Jolesz FA; Guttmann CR
    Neurology; 2003 Feb; 60(4):640-6. PubMed ID: 12601106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal evolution of acute multiple sclerosis lesions on serial sodium (
    Eisele P; Konstandin S; Szabo K; Ebert A; Roßmanith C; Paschke N; Kerschensteiner M; Platten M; Schoenberg SO; Schad LR; Gass A
    Mult Scler Relat Disord; 2019 Apr; 29():48-54. PubMed ID: 30669020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly multimodal MRI follow-up of two multiple sclerosis active lesions presenting a transient decrease in ADC.
    Hannoun S; Roch JA; Durand-Dubief F; Vukusic S; Sappey-Marinier D; Guttmann CR; Cotton F
    Brain Behav; 2015 Feb; 5(2):e00307. PubMed ID: 25642392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial isotropic three-dimensional fast FLAIR imaging: using image registration and subtraction to reveal active multiple sclerosis lesions.
    Tan IL; van Schijndel RA; Pouwels PJ; Adèr HJ; Barkhof F
    AJR Am J Roentgenol; 2002 Sep; 179(3):777-82. PubMed ID: 12185063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI FLAIR lesion segmentation in multiple sclerosis: Does automated segmentation hold up with manual annotation?
    Egger C; Opfer R; Wang C; Kepp T; Sormani MP; Spies L; Barnett M; Schippling S
    Neuroimage Clin; 2017; 13():264-270. PubMed ID: 28018853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI.
    Maranzano J; Dadar M; Rudko DA; De Nigris D; Elliott C; Gati JS; Morrow SA; Menon RS; Collins DL; Arnold DL; Narayanan S
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1162-1169. PubMed ID: 31221631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relating multi-sequence longitudinal intensity profiles and clinical covariates in incident multiple sclerosis lesions.
    Sweeney EM; Shinohara RT; Dewey BE; Schindler MK; Muschelli J; Reich DS; Crainiceanu CM; Eloyan A
    Neuroimage Clin; 2016; 10():1-17. PubMed ID: 26693397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of acute "black hole" lesions in patients with relapsing-remitting multiple sclerosis.
    Kostic D; Dincic E; Jovanovski A; Kostic S; Rancic N; Georgievski-Brkic B; Misovic M; Koprivsek K
    Acta Neurol Belg; 2023 Jun; 123(3):831-838. PubMed ID: 35397094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
    Elliott C; Wolinsky JS; Hauser SL; Kappos L; Barkhof F; Bernasconi C; Wei W; Belachew S; Arnold DL
    Mult Scler; 2019 Dec; 25(14):1915-1925. PubMed ID: 30566027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TSPO PET with [
    Unterrainer M; Mahler C; Vomacka L; Lindner S; Havla J; Brendel M; Böning G; Ertl-Wagner B; Kümpfel T; Milenkovic VM; Rupprecht R; Kerschensteiner M; Bartenstein P; Albert NL
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1423-1431. PubMed ID: 29523925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.
    Jurcoane A; Wagner M; Schmidt C; Mayer C; Gracien RM; Hirschmann M; Deichmann R; Volz S; Ziemann U; Hattingen E
    J Magn Reson Imaging; 2013 Dec; 38(6):1454-61. PubMed ID: 23554005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of contrast-enhanced fluid-attenuated inversion-recovery and delayed contrast-enhanced brain MRI in multiple sclerosis.
    Bagheri MH; Meshksar A; Nabavizadeh SA; Borhani-Haghighi A; Ashjazadeh N; Nikseresht AR
    Acad Radiol; 2008 Jan; 15(1):15-23. PubMed ID: 18078903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of Brain Atrophy Measurement in Clinical Routine without Prior Standardization of the MRI Protocol: Results from MS-MRIUS, a Longitudinal Observational, Multicenter Real-World Outcome Study in Patients with Relapsing-Remitting MS.
    Zivadinov R; Bergsland N; Korn JR; Dwyer MG; Khan N; Medin J; Price JC; Weinstock-Guttman B; Silva D;
    AJNR Am J Neuroradiol; 2018 Feb; 39(2):289-295. PubMed ID: 29170269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of sagittal short T1 inversion recovery and T2-weighted FSE sequences for detection of multiple sclerosis spinal cord lesions.
    Nayak NB; Salah R; Huang JC; Hathout GM
    Acta Neurol Scand; 2014 Mar; 129(3):198-203. PubMed ID: 23980614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of 3D fluid attenuated inversion recovery sequence in multiple sclerosis.
    Gramsch C; Nensa F; Kastrup O; Maderwald S; Deuschl C; Ringelstein A; Schelhorn J; Forsting M; Schlamann M
    Acta Radiol; 2015 May; 56(5):622-7. PubMed ID: 24867222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Three Times a Week Glatiramer Acetate on Cerebral T1 Hypointense Lesions in Relapsing-Remitting Multiple Sclerosis.
    Zivadinov R; Dwyer MG; Ramasamy DP; Davis MD; Steinerman JR; Khan O
    J Neuroimaging; 2015; 25(6):989-95. PubMed ID: 26394270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MRI time series modeling of MS lesion development.
    Meier DS; Guttmann CR
    Neuroimage; 2006 Aug; 32(2):531-7. PubMed ID: 16806979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.